Horizon Two: HR NDMM (MMRC-100)

Clinical trial NCT07053436 · RECRUITING

Trial details

NCT number: NCT07053436
Sponsor: Multiple Myeloma Research Consortium
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

High Risk Newly Diagnosed Multiple Myeloma

Start date: 2026-04-30
Primary completion: 2035-10-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.